RCA Regional Office E-learning

e-Learning

home
e-Learning Modules
Nuclear Medicine
Oncology

Oncology

Hodgkin′s Lymphoma

First Seminar of the Korean Society of Blood transfusion's Immunology and Hematology Committee in 2019
Lecturer Narjess Ayati MD, IBNM, FEBNM, ABNC, FANMB
Objectives Overall objectives

On successful completion of this activity, participant should have an overview of Hodgkin’s lymphoma (HL), and the role of FDG-PET/CT in patient management.

Specific objectives

Following completion of this activity, the participant will achieve a brief knowledge about Hodgkin’s lymphoma including:
Epidemiology & Risk factors
Prognosis and prognostic factors
Clinical presentation
Classification
Initial diagnosis & staging
Patient management
Role of FDG PET/CT in HL
Response assessment criteria (including Deauville 5-point scoring system)
Video 24min
Guide Sentence · It is recommended to pause frequently to read details of a slide.
· It may take time to load the lecture subject to internet connectivity of each user.

Subtitle

Only members can take the test. Please log-in and watch the modules fully to take the test. Login
Test

Lecturer

Narjess Ayati, MD, IBNM, FEBNM, ABNC, FANMB
Department of Molecular Imaging and Therapy
Austin Health, Melbourne, Australia
E-mail:n_ayati@yahoo.com
Sze Ting LEE, MBBS, PhD, FRACP, FAANMS, Associate Professor
Department of Molecular Imaging & Therapy,
Austin Health, Victoria, Australia
E-mail:sze.ting.lee@bigpond.com
List